Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Onyx
 More »

  • Takeover Targets: Who Is First on the List?
    Biotech Stocks Are Buyout Targets after Onyx Pharmaceutical Rejects Amgen? " July-One ... Biotech Stocks Are Buyout Targets after Onyx Pharmaceutical Rejects Amgen? " July-One ...
    9-24-2013
  • As Big Deals Resurface, Who's Next to the Altar?
    Amgen-Onyx, Perrigo-Elan warm an M&A space that had been chilled by an IPO revival. Amgen's planned acquisition of Onyx Pharmaceuticals was a reminder of how quiet the M&A market ...
    9-9-2013
  • Amgen Grows Cancer Holdings with $10.4B Onyx Acquisition
    circles yesterday when it said it plans to acquire Onyx Pharmaceuticals for $10.4 billion. ... The boards of both Amgen and Onyx have approved the deal, which is still subject to ...
    8-26-2013
  • The 20 Top Paid Women Executives in Biopharma
    ... 2011 Compensation: N/A 3 % Change: N/A 3 #15. Suzanne M. Shema, J.D. Company: Onyx Pharmaceuticals Title: EVP, General Counsel and Corporate Secretary 2012 Compensation: ...
    8-5-2013
  • Novo Nordisk Tops GEN List of Top 25 Biotech Companies
    Isis Pharmaceuticals (NASDAQ:ISIS), Onyx Pharmaceuticals (NASDAQ:ONXX), Vertex Pharmaceuticals (NASDAQ:VRTX), and especially Gilead, which nearly tripled its market cap. ...
    7-25-2013
  • Top 25 Biotech Companies of 2013
    ... shares * price Rs. 1764.75 on 3/30) 1,2 % Change: 0.3% Position on 2012 List: #17 #17. Onyx Pharmaceuticals 2013 Market Cap: $6.580 billion (5/3: 72,738,263 shares * price $90.46) ...
    7-15-2013
  • Onyx Spurns Amgen Offer, Pursues Its Own Deal
    Onyx Pharmaceuticals said yesterday it has begun shopping for its own would-be buyer ... exploring the potential to combine Onyx with another company as an option to ...
    7-1-2013
  • Onyx, UCSF Forge Cancer Innovation Alliance
    Onyx Pharmaceuticals is teaming up with the University of California, San Francisco (UCSF) ... science and medicine at both UCSF and Onyx to address the full continuum of that care ...
    6-3-2013
  • Merck, BMS Immunotherapy Data Whets Clinical Oncology Appetite...
    Meantime, Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals said their Nexavar® (sorafenib) improved median progression-free survival in patients with locally advanced or ...
    6-3-2013
  • GEN | Biolinks
    ... OncoMed Pharmaceuticals, Inc Onconova Therapeutics, Inc OneWorld Health (PATH affiliate) Onyx Pharmaceuticals, Inc Opexa Therapeutics OPX Biotechnologies, Inc. Oregon Bioscience ...
  • Top 20 Best-Selling Drugs Approved and Launched During 2012
    ... 12,13 Marketer(s): Bayer HealthCare and Onyx Pharmaceuticals Indication(s): Metastatic ... 2012 sales: $64 million Marketer(s): Onyx Pharmaceuticals Indication(s): Multiple ...
    4-4-2013
  • Scaling Up Peptide Drugs
    anemia due to chronic kidney disease in adults on dialysis; Kyprolis(tm) (carfilzomib, Onyx Pharmaceuticals) a proteasome inhibitor to treat multiple myeloma; Gattex (teduglutide, ...
    4-1-2013
  • People in the News
    Previously, he was managing sales and business development at Zymark. He was also managing director of Caliper LS. Adam Moorhouse joined Onyx as a director of business ...
    4-1-2013
  • FDA Blocks Novo, Boosts Celgene
    ... Pomalyst is the second MM drug approved by FDA in the past year. In July, the agency approved Onyx Pharmaceuticals' Kyprolis (carfilzomib). Both drugs were reviewed through FDA's ...
    2-11-2013
  • People in the News
    ... Prior to joining Sepracor, he was the svp and head of the cardiovascular business unit at Novartis Pharmaceuticals. Onyx Pharmaceuticals named N. Anthony Coles, M.D. , as chairman ...
    1-15-2013

  • Journal Articles

  • Successful Uterine Artery Embolization for Intractable Postpartum...
    Maria I. Pardo, Maria V. Trujillo, Silvia Campos, Verónica Lázaro, Giselle Romero, Alexandra Banguero, Jose Manuel Pumar, María V Trujillo
    Journal of Gynecologic Surgery
    Hemorrhage Using a Novel Embolic Agent: ONYX Journal of Gynecologic Surgery Abstract ... As standard procedures had failed to achieve full hemostasis, a new embolic agent "Onyx" ...
  • Lister Vaccine Strain of Vaccinia Virus Armed with the Endostatin...
    James R Tysome, Pengju Wang, Ghassan Alusi, Arnaud Briat, Rathi Gangeswaran, Jiwei Wang, Vipul Bhakta, Istvan Fodor, Nick R. Lemoine, Yaohe Wang
    Human Gene Therapy and Part B: Methods
    An Oncolytic Virus Superior to dl 1520 (ONYX-015) for Human Head and Neck Cancer Human ... with dl1520 (ONYX-015) the most widely used oncolytic adenovirus in clinical trials. ...
  • Human Telomerase Reverse Transcriptase Promoter-Driven Oncolytic...
    Joshua C. Doloff, David J. Waxman, Youssef Jounaidi
    Human Gene Therapy and Part B: Methods
    E3B-region-deleted oncolytic adenovirus ONYX-015. Tumor cells infected with ... apoptotic index than cells infected with ONYX-015. Despite the increase in virus-induced ...
  • Potent Antitumor Activity of Oncolytic Adenovirus Expressing...
    Lili Zhao, Jinfa Gu, Aiwen Dong, Yanhong Zhang, Liu Zhong, Lingfeng He, Yigang Wang, Jinhe Zhang, Zilai Zhang, Jin Huiwang, Qijun Qian, Cheng Qian, Xinyuan Liu
    Human Gene Therapy and Part B: Methods
    tumors with ZD55-IL-24 showed much stronger antitumor activity than that induced by ONYX-015 or Ad-IL- 24. These data indicated that oncolytic adenovirus expressing IL-24 could ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll